Logical Therapeutics is a privately held biopharmaceutical company focused on the development of novel drugs to treat diseases characterized by excessive inflammation.
Inflammation is a key component of the body's response to injury or infection. When it is properly regulated and controlled, inflammation is beneficial because it promotes the healing of wounds and participates in the defending the body against infection by pathogenic microbes. However, poorly controlled inflammation contributes to the pathogenesis of diseases such as rheumatoid arthritis and osteoarthritis. Additionally, it is increasingly apparent that chronic inflammation is also a factor in the development of a host of other chronic diseases, including diabetes mellitus, metabolic syndrome, certain digestive disorders, asthma, atherosclerotic heart disease and even cancer.
Each of the inflammation-related drug development programs at Logical Therapeutics addresses an unmet medical need and a large potential market.
Contact Us
300 Second Avenue
Waltham, MA 02451
781.290.0900 phone
781.290.0911 fax
info@logicaltherapeutics.com